DNA damage response in tumours of patients with endometrial cancer
Recruiting
- Conditions
- Endometrial cancer
- Registration Number
- NL-OMON23000
- Lead Sponsor
- ErasmusMC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
Patients with all subtypes of endometrial cancer
Exclusion Criteria
Patients will be informed upfront that any relevant findings in this study will be reported back to themselves and to their attending physicians. They cannot participate in the study when they do not consent to these criteria.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We hope to find a way to perform ex- vivo testing of the respons to several therapies in fresh tumour tissue
- Secondary Outcome Measures
Name Time Method